Title : Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.

Pub. Date : 2010 Apr 1

PMID : 19965642






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In CLL patients receiving lenalidomide, similar evidence of CD154 activation is observed including BID, DR5, and p73 induction and also development of anti-ROR1 tumor-directed antibodies. Lenalidomide BH3 interacting domain death agonist Homo sapiens